The purpose of the study is to assess the tolerability and efficacy of dextromethorphan in combination with fluoxetine for symptom relief in OCD and related disorders.
Diagnosis of obsessive-compulsive disorder (OCD), body dysmorphic disorder (BDD), illness anxiety disorder (IAD) or somatic symptom disorder (SSD)
Living within California
Capacity to provide informed consent
Current bipolar disorder or psychotic disorder
Active moderate or severe substance use disorder, lifetime severe substance use disorder
Pregnant or nursing women
Use of prescribed psychotropic medications other than fluoxetine for 2 weeks prior to study start
Stanford University
Lead sponsor
Avy L. & Roberta L. Miller Foundation
Collaborator